Definitive Healthcare Corp. (DH)
NASDAQ: DH · Real-Time Price · USD
3.255
-0.025 (-0.76%)
At close: May 28, 2025, 4:00 PM
3.250
-0.005 (-0.15%)
After-hours: May 28, 2025, 4:00 PM EDT
Definitive Healthcare Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for Definitive Healthcare stock ranges from a low of $3.00 to a high of $7.50. The average analyst price target of $5.10 forecasts a 56.68% increase in the stock price over the next year.
Price Target: $5.10 (+56.68%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Definitive Healthcare stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 8 | 7 | 7 | 7 | 7 | 6 |
| Sell | 1 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Hold Maintains $3 → $3.4 | Hold | Maintains | $3 → $3.4 | +4.45% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $4.5 → $3 | Hold | Maintains | $4.5 → $3 | -7.83% | Mar 4, 2025 |
| Barclays | Barclays | Sell Maintains $4 → $3 | Sell | Maintains | $4 → $3 | -7.83% | Mar 3, 2025 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Jan 16, 2025 |
| Barclays | Barclays | Hold → Sell Downgrades $4 | Hold → Sell | Downgrades | $4 | +22.89% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
243.93M
from 252.20M
Decreased by -3.28%
Revenue Next Year
248.59M
from 243.93M
Increased by 1.91%
EPS This Year
0.22
from -3.54
EPS Next Year
0.26
from 0.22
Increased by 18.10%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 250.2M | 267.0M | 284.5M |
| Avg | 243.9M | 248.6M | 250.7M |
| Low | 229.3M | 222.4M | 212.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.8% | 9.4% | 14.5% |
| Avg | -3.3% | 1.9% | 0.8% |
| Low | -9.1% | -8.8% | -14.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.28 | 0.40 | 0.47 |
| Avg | 0.22 | 0.26 | 0.30 |
| Low | 0.20 | 0.20 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 78.1% | 78.6% |
| Avg | - | 18.1% | 14.8% |
| Low | - | -12.5% | -25.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.